• Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (PubMed=22383533).
  
• Mutation; HGNC; HGNC:3432; ERBB4; Simple; p.Glu452Lys (c.1354G>A); ClinVar=VCV000091898; Zygosity=Heterozygous (PubMed=22383533).
  

PubMed=4153924
Janiaud P., Le Calvez J., Aubert C.
Cytoenzymological caracterization of cells from human skin melanoma in culture.
Ann. Dermatol. Syphiligr. (Paris) 100:536-539(1973)

PubMed=1171141; DOI=10.4049/jimmunol.115.2.539
Peter H.H., Pavie-Fischer J., Fridman W.H., Aubert C., Cesarini J.-P., Roubin R., Kourilsky F.M.
Cell-mediate cytotoxicity in vitro of human lymphocytes against a tissue culture melanoma cell line (IGR3).
J. Immunol. 115:539-548(1975)

PubMed=954556; DOI=10.1016/0014-2964(76)90033-5
Aubert C., Lagrange C., Rorsman H., Rosengren E.
Catechols in primary and metastatic human malignant melanoma cells in monolayer culture.
Eur. J. Cancer 12:441-445(1976)

PubMed=405430; DOI=10.1111/1523-1747.ep12496554
Foa C., Aubert C.
Cellular localization of tyrosinase in human malignant melanoma cell lines.
J. Invest. Dermatol. 68:369-378(1977)

PubMed=6929009; DOI=10.1093/jnci/64.5.1029
Aubert C., Rouge F., Galindo J.-R.
Tumorigenicity of human malignant melanocytes in nude mice in relation to their differentiation in vitro.
J. Natl. Cancer Inst. 64:1029-1040(1980)

PubMed=6539703; DOI=10.1016/0277-5379(84)90015-4
Weinreb A., Travo P.
Discrimination between human melanoma cell lines by fluorescence anisotropy.
Eur. J. Cancer Clin. Oncol. 20:673-677(1984)

PubMed=2337917
Aquaron R., Dutoit C., Reynier M., Aubert C.
Calmodulin content and distribution in six human melanoma cell lines.
Cell. Mol. Biol. 36:85-92(1990)

PubMed=7520026; DOI=10.1002/ijc.2910580413
Hersey P., Si Z.-Y., Smith M.J., Thomas W.D.
Expression of the co-stimulatory molecule B7 on melanoma cells.
Int. J. Cancer 58:527-532(1994)

PubMed=8980186; DOI=10.1002/(SICI)1097-0215(19961211)68:6<795::AID-IJC18>3.0.CO;2-#
Thomas W.D., Smith M.J., Si Z.-Y., Hersey P.
Expression of the co-stimulatory molecule CD40 on melanoma cells.
Int. J. Cancer 68:795-801(1996)

PubMed=9725211; DOI=10.4049/jimmunol.161.5.2195
Thomas W.D., Hersey P.
TNF-related apoptosis-inducing ligand (TRAIL) induces apoptosis in Fas ligand-resistant melanoma cells and mediates CD4 T cell killing of target cells.
J. Immunol. 161:2195-2200(1998)

PubMed=22383533; DOI=10.1158/1535-7163.MCT-11-0676
Dutton-Regester K., Irwin D., Hunt P., Aoude L.G., Tembe V., Pupo G.M., Lanagan C., Carter C.D., O'Connor L., O'Rourke M., Scolyer R.A., Mann G.J., Schmidt C.W., Herington A., Hayward N.K.
A high-throughput panel for identifying clinically relevant mutation profiles in melanoma.
Mol. Cancer Ther. 11:888-897(2012)